For citations:
Kovalenko E.I., Zhulikov Ya.A., Artamonova E.V., Khoroshilov M.V., Petrovskiy A.V., Denchik D.A., Vorotnikov I.K. Efficacy of dose-dense versus standard neoadjuvant chemotherapy regimensin luminal HER2-negative breast cancer: Interim results of single-centre study. Medical alphabet. 2023;(27):21-27. (In Russ.) https://doi.org/10.33667/2078-5631-2023-27-21-27